ArticleThe Journal of infectious diseases2021

Monoclonal Antibody Requires Immunomodulation for Efficacy Against Acinetobacter baumannii Infection.

Travis B Nielsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.